Pharmaceutical Investing Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
Pharmaceutical Investing VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study
Pharmaceutical Investing Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE
Pharmaceutical Investing Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients
